| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |